See All Slides - tctmd.com

Slides

Presentation NY Valves 2024

SMART Says That Self Expanding Valves Are Best!

Presenter: Howard C. Herrmann

June 06, 2024

Presentation NY Valves 2024

Debate Pro

Presenter: Howard C. Herrmann

June 06, 2024

Presentation NY Valves 2024

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

A Novel Invasive Hemodynamic Parameter (V’) to Predict Clinical Outcomes Following Mitral Transcatheter Edge-to-Edge Repair (M-TEER)

Presenter: Maryam Muhammad Ali Majeed-Saidan

June 06, 2024

Presentation NY Valves 2024

Debate Con: Echo First and Only to Diagnose Bioprosthetic Valve Dysfunction /Failure

Presenter: Rebecca T. Hahn

June 06, 2024

Presentation NY Valves 2024

The Value of Delta Left Atrial Pressure Ratio as a Novel Predictor of Outcomes After Mitral Transcatheter Edge-to-Edge Repair

Presenter: Yasser M. Sammour

June 06, 2024

Presentation NY Valves 2024

Expanding the Reach of Transseptal TMVR: The AltaValve’s Atrial Fixation Allows Treatment for a Broader Patient Population

Presenter: Vlasis Ninios

June 06, 2024

Presentation NY Valves 2024

Treating the Ineligible: Patients With Low Cardiac Index Treated With Atrial Fixation TMVR

Presenter: Vlasis Ninios

June 06, 2024

Presentation NY Valves 2024

TAVR-in-TAVR for an Early Degenerated Bio-Prosthesis

Presenter: Vivek Patel

June 06, 2024

Presentation NY Valves 2024

TAVR Will Have a Longer Lasting Durability Than SAVR

Presenter: Michael J. Reardon

June 06, 2024

Advertisement

Slides

SMART Says That Self Expanding Valves Are Best!

Debate Pro

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

A Novel Invasive Hemodynamic Parameter (V’) to Predict Clinical Outcomes Following Mitral Transcatheter Edge-to-Edge Repair (M-TEER)

Debate Con: Echo First and Only to Diagnose Bioprosthetic Valve Dysfunction /Failure

The Value of Delta Left Atrial Pressure Ratio as a Novel Predictor of Outcomes After Mitral Transcatheter Edge-to-Edge Repair

Expanding the Reach of Transseptal TMVR: The AltaValve’s Atrial Fixation Allows Treatment for a Broader Patient Population

Treating the Ineligible: Patients With Low Cardiac Index Treated With Atrial Fixation TMVR

TAVR-in-TAVR for an Early Degenerated Bio-Prosthesis

TAVR Will Have a Longer Lasting Durability Than SAVR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content